Parallel track regulations

Executive Summary

National Institute of Allergy and Infectious Diseases' AIDS Research Advisory Committee emphasizes a "sincere desire for a definitive decision on the stalled parallel track initiative" in a Feb. 12 letter to NIAID Director Anthony Fauci, MD. The initiative would establish rules for NIAID's mechanism for expanded access to drugs still in clinical trials but has languished in the Office of Management and Budget for over a year. ARAC Chairman Gerald Medoff contended that parallel track "offers substantial improvements over the current ad hoc situation." The letter is expected to be sent to HHS' National AIDS Program Office.